Applied DNA Sciences develops and markets DNA-based technology solutions utilizing its LinearDNA polymerase chain reaction (PCR) based manufacturing platform. Co.'s proprietary platform produces DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes applications. In addition, Co. has developed a PCR-based molecular diagnostic test for COVID-19. Co. manufactures and sells its Emergency Use Authorization authorized COVID-19 molecular diagnostic test kit under the Linea COVID-19 Assay Kit trademark. The APDN stock yearly return is shown above.
The yearly return on the APDN stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2016 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the APDN annual return calculation with any dividends reinvested as applicable (on ex-dates).
|